MAZE (Maze Therapeutics) Float Percentage Of Total Shares Outstanding: 88.76% (As of Jul. 03, 2026)


MAZE Maze Therapeutics Inc MAZE
14 GF Score
Price $31.25
! 2 Warning Signs
View Full Analysis

What is Maze Therapeutics Float Percentage Of Total Shares Outstanding?

Maze Therapeutics MAZE +5.01% 14 Float Percentage Of Total Shares Outstanding is 88.76% as of Jul. 03, 2026. GuruFocus rates MAZE with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Maze Therapeutics's float shares is 49.13 Mil. Maze Therapeutics's total shares outstanding is 55.35 Mil. Maze Therapeutics's float percentage of total shares outstanding is 88.76%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Maze Therapeutics's Insider Ownership is 1.10%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Maze Therapeutics's Institutional Ownership is 96.45%.

MAZE
14GF Score
Maze Therapeutics Inc MAZE
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maze Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Maze Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=49.13/55.35
=88.76%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 88.76% mean?
Maze Therapeutics (MAZE) has a Float Percentage Of Total Shares Outstanding of 88.76% as of Jul. 03, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Maze Therapeutics and its competitors.
Is Maze Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Maze Therapeutics' current Float Percentage Of Total Shares Outstanding is 88.76%. Overall, Maze Therapeutics has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Maze Therapeutics' Float Percentage Of Total Shares Outstanding compare to AVBP and DMRA?
Maze Therapeutics' Float Percentage Of Total Shares Outstanding of 88.76% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Maze Therapeutics and its competitors. Maze Therapeutics's current Float Percentage Of Total Shares Outstanding is 88.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maze Therapeutics stock overvalued right now?
Maze Therapeutics (MAZE) has a current Float Percentage Of Total Shares Outstanding of 88.76%. The current Float Percentage Of Total Shares Outstanding is 88.76%. Maze Therapeutics' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Maze Therapeutics (MAZE), the current Float Percentage Of Total Shares Outstanding is 88.76% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maze Therapeutics Business Description

Address 171 Oyster Point boulevard, Suite 300, South San Francisco, CA, USA, 94080
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
14GF Score

Get the complete analysis for MAZE

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.25
Price